SCHEMBL8986957

SCHEMBL8986957

O=C(O)CCCCCOc1ncc(-c2ccccc2)c(-c2ccccc2)n1

nearest known ligand 0.57

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 14/20 0.57
FABP3 P05413 1/20 0.50
FABP4 P15090 1/20 0.50
PTGIR P43119 3/20 0.49
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
NR4A2 P43354 1/20 0.43
FABP1 P07148 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9291667 1.00 LTB4R (0.57) LTB4RFABP3FABP4PTGIRRXRA
SCHEMBL8987144 1.00 LTB4R (0.57) LTB4RFABP3FABP4PTGIRRXRA
SCHEMBL8987118 0.89 LTB4R (0.57) LTB4RFABP3FABP4RXRARXRB
SCHEMBL8987233 0.88 LTB4R (0.54) LTB4R
SCHEMBL8987182 0.87 LTB4R (0.52) LTB4R
SCHEMBL8987198 0.86 FAAH (0.51) LTB4R
SCHEMBL3571567 0.83 PTGIR (0.50) LTB4RFABP3FABP4PTGIRRXRA
SCHEMBL8987151 0.81 PTGIR (0.41) LTB4RFABP3FABP4PTGIRRXRA
Bicarbonate SCHEMBL3917634 0.80 ADORA1 (0.39) LTB4RPTGIR
SCHEMBL5407468 0.80 LTB4R (0.62) LTB4RFABP3FABP4PTGIR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0718682-A1 Silver halide photographic emulsions prepared and sensitized in the presence of sulfodihydroxy aryl compounds EASTMAN KODAK COMPANY (US) 1996-06-26 EP disclosed
US-5492915-A ANTIINFLAMMATORY AGENTS RHONE-POULENC RORER S.A. (FR) 1996-02-20 US disclosed
US-5366982-A Antiinflammatory agents or antihistamines RHONE-POULENC RORER S.A. (FR) 1994-11-22 US disclosed
EP-0540604-A1 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS Aventis Pharma S.A. (FR) 1993-05-12 EP disclosed
WO-1992001675-A2 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO disclosed